Curvaceous model of recovery from depression.
Livingston
M G
MG
University Department of Psychological Medicine, Gartnavel Royal Hospital, Glasgow.
Clark
A
A
D000928:Antidepressive Agents / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D003511:Cyclohexanols / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D015233:Models, Statistical; D010879:Piperazines; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D010879:Piperazines; D014230:Triazoles; D015283:Citalopram; C051752:nefazodone; D000069470:Venlafaxine Hydrochloride